Summaries & Associations of Study Results
TR-242 Diallyl phthalate
Target Organs and Levels of Evidence
NTP Technical Report Number 242
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| DIALLYL PHTHALATE 131-17-9 |
06/16/82 | FORMS LAMINATES WITH VARIOUS FILLERS (E.G. GLASS CLOTH). ELECTRICAL INSULATION. DYE CARRIER. PRIMARY PLASTICIZER. (TDB) | Gavage 0,150,300 MG/KG/50 PER GROUP | Litton Bionetics, Inc. |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MM: EQUIVOCAL | FORESTOMACH: SQUAMOUS CELL PAPILLOMA 0/49 1/47 2/49 | |||
| HEMATOPOIETIC SYSTEM: LYMPHOMA 6/50 5/50 12/50 | ||||
| NON-NEOPLASTIC LESIONS: | FORESTOMACH: INFLAMMATION, CHRONIC; HYPERPLASIA | |||
| FM: EQUIVOCAL | FORESTOMACH: SQUAMOUS CELL PAPILLOMA 0/48 1/47 2/49 | |||
| NON-NEOPLASTIC LESIONS: | FORESTOMACH: INFLAMMATION, CHRONIC; HYPERPLASIA | |||
Web page last updated on February 10, 2006
